Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,250
Closed -$353K 131
2025
Q3
$353K Hold
1,250
0.15% 98
2025
Q2
$349K Hold
1,250
0.21% 62
2025
Q1
$389K Hold
1,250
0.19% 88
2024
Q4
$326K Hold
1,250
0.17% 72
2024
Q3
$403K Hold
1,250
0.21% 64
2024
Q2
$391K Sell
1,250
-235
-16% -$69K 0.22% 65
2024
Q1
$422K Hold
1,485
0.25% 57
2023
Q4
$428K Sell
1,485
-90
-6% -$24.5K 0.28% 53
2023
Q3
$423K Hold
1,575
0.34% 49
2023
Q2
$350K Buy
1,575
+725
+85% +$168K 0.29% 64
2023
Q1
$205K Sell
850
-30
-3% -$7.36K 0.23% 73
2022
Q4
$231K Sell
880
-49
-5% -$13.1K 0.29% 67
2022
Q3
$210K Sell
929
-25
-3% -$6.06K 0.28% 69
2022
Q2
$232K Buy
954
+54
+6% +$13.2K 0.27% 68
2022
Q1
$218K Hold
900
0.2% 82
2021
Q4
$202K Buy
+900
New +$190K 0.18% 95

Other funds holding AMGN

SFG Wealth Management's AMGN Position: Q4 2025 in Review

SFG Wealth Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 1,250 shares — an estimated $353K sold.

SFG Wealth Management first reported a position in AMGN in Q4 2021 and held it in 16 quarters. The position peaked at $428K in Q4 2023. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • SFG Wealth Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • SFG Wealth Management sold 1,250 Amgen shares in Q4 2025, an estimated $353K.
  • SFG Wealth Management first reported a position in Amgen in Q4 2021 and held it in 16 quarters.
  • SFG Wealth Management's Amgen position peaked at $428K in Q4 2023.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on SFG Wealth Management's 13F filing for Q4 2025, filed 3 Feb 2026.